BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Press Releases

  OPKO Health Reports Second Quarter 2024 Business Highlights and Financial Results

  August 8, 2024

   · 

  11 min read
• Press Releases

  Medexus Announces Strong Fiscal Q1 2025 Results

  Fiscal Q1 2025 revenue of $27.3 million, net income of $2.0 million, operating income of $4.0 million, and Adjusted EBITDA* of $6.1 million Management to host conference call at 8:00 AM Eastern time on Thursday, August 8, 2024

  August 8, 2024

   · 

  20 min read
• Press Releases

  CG Oncology Reports Second Quarter 2024 Financial Results and Provides Business Updates

  August 8, 2024

   · 

  7 min read
• Press Releases

  Opthea to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference, August 15, 2024

  August 8, 2024

   · 

  1 min read
• Press Releases

  Intra-Cellular Therapies to Present at the Canaccord Genuity 44th Annual Growth Conference

  August 8, 2024

   · 

  1 min read
• Press Releases

  Third Harmonic Bio Announces Second Quarter 2024 Financial Results and Provides Business Update

  August 8, 2024

   · 

  6 min read
• Press Releases

  Phathom Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update

  August 8, 2024

   · 

  14 min read
• Press Releases

  Evaxion to Present One-Year Clinical Efficacy Data from its Phase 2 Study on Lead Cancer Vaccine Candidate, EVX-01, at the ESMO Congress 2024 in September

  August 8, 2024

   · 

  4 min read
• Press Releases

  Vera Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results

  August 8, 2024

   · 

  9 min read
• Press Releases

  Palisade Bio Selects Dose for Upcoming Phase 1 Clinical Study of PALI-2108 for Ulcerative Colitis

  August 8, 2024

   · 

  5 min read